Athira pharma mourns the loss of chair of board of directors, tadataka yamada, m.d.

Bothell, wash., aug. 05, 2021 (globe newswire) -- athira pharma, inc. (nasdaq: atha), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration, mourns the passing of tadataka “tachi” yamada, m.d., the chair of the company's board of directors.

ATHA Ratings Summary

ATHA Quant Ranking